Overview

Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
Sevoflurane is an FDA-approved anesthetic drug commonly used for anesthesia during second trimester abortion procedures. It has a few advantages, including ease of use by the anesthesia provider. However, the literature suggests that when used in doses higher than those used at Oregon Health & Science University (OHSU) and Lovejoy, it is associated with an increase in the risk of bleeding. The investigators study aims to test whether the lower dose used at OHSU and Lovejoy during second trimester abortion procedures causes any difference in blood loss, when compared to similar abortion procedures for which this drug is not used.
Phase:
Phase 4
Details
Lead Sponsor:
Oregon Health and Science University
Treatments:
Anesthetics
Sevoflurane